Atlas Trials

Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder

RecordFirmDate
Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma (NCT06723457)Reem Karmali2025-07-25
Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders (NCT06672705)Timothy Voorhees2025-06-16
Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder (NCT02900976)Children's Oncology Group2017-03-22

Track Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder automatically

Every clearance here is in the API, with alerts when new ones post.